Groove carving structure and medical support

By designing the grooved structure in the drug-eluting stent, the drug coating is partially accommodated in the groove and partially covers the groove shoulder. By adjusting the structure, the problem of drug release rate and firmness is solved, and the stable release of the drug is achieved. Effective treatment effect.

CN118903656APending Publication Date: 2024-11-08MICROPORT NEUROTECH SHANGHAI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310511344.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-08
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing drug-eluting stents cannot take into account both drug release rate and drug firmness, resulting in problems such as the risk of drug shedding and the release rate being difficult to control.

Method used

A grooved structure is designed in which part of the drug coating is accommodated in the groove and the other part covers the groove shoulder, the drug release rate is controlled by adjusting the structure of the groove shoulder and groove, and through the second groove and projection It improves the bonding strength and release efficiency of the drug coating.

Benefits of technology

It effectively reduces the risk of drug coating shedding, controls the drug release rate, increases the contact area and binding strength between the drug and vascular tissue, reduces the risk of acute thrombosis, and ensures the effective release and therapeutic effect of the drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903656A_ABST
    Figure CN118903656A_ABST
Patent Text Reader

Abstract

The invention provides a notch groove structure and a medical support. The notch groove structure comprises a body, a groove and a medicine coating. The groove is located on the body, a groove shoulder is formed on a part of the outer surface of the body, and the groove shoulder is located on at least one side of an opening of the groove; one part of the medicine coating is contained in the groove, and the other part of the medicine coating covers at least one part of the groove shoulder. According to the configuration, one part of the medicine coating is contained in the groove, the other part of the medicine coating covers at least one part of the groove shoulder, an operator can control the contact area of the medicine coating and vascular tissue by adjusting the medicine carried by the groove shoulder and the thickness of the medicine coating in the groove, and then the release rate of the medicine coating is controlled.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medical devices, in particular to a groove structure and a medical bracket. Background Art

[0002] Atherosclerosis is an important cause of vascular stenosis and tissue ischemia. According to the "pan-vascular" theory, vascular atherosclerotic stenosis can occur in arteries throughout the body, such as the internal carotid artery, carotid artery, coronary artery, iliac artery, femoral artery, popliteal artery, etc. Vascular intervention is an effective means of treating atherosclerotic vascular stenosis. Its treatment options have evolved from simple balloon dilatation, bare metal stent dilatation, drug-eluting stent dilatation, drug balloon dilatation, and degradable drug stent dilatation. At present, drug-eluting stents have become the mainstream treatment of vascular atherosclerotic stenosis due to the good inhibitory effect of drugs on smooth muscle cells and the excellent support of bare metal stents.

[0003] Existing drug-eluting stent drug loading methods include ultrasonic full spray loading, groove loading, microporous loading, etc. Among them, groove loading not only ensures the effective amount of drug for vascular lesions through the single-sided groove loading of the stent, but also avoids the wear and peeling of the drug coating. The drug coating can effectively act on the time window of smooth muscle proliferation through the drug release mechanism, and effectively inhibit the proliferation of smooth muscle cells, but will not affect the endothelialization of the stent. On the one hand, the groove loading method will affect the drug release rate due to the different drug components in the drug groove. On the other hand, the structure of the drug groove will also affect the drug release mechanism and the firmness of the drug coating in the drug groove.

[0004] The existing drug slots have the following problems: the drug will fall off when the drug loading is guaranteed, and the drug release rate is not easy to control. Therefore, a new drug distribution method in the drug slot and a new drug slot structure design are needed. Under the condition of ensuring effective control of drug release, the risk of drug coating falling off can be reduced by designing the drug slot structure to achieve drug effectiveness. Summary of the invention

[0005] The purpose of the present invention is to provide a groove structure and a medical stent to solve the problem that the existing stent cannot take into account both the controlled drug release rate and the drug firmness.

[0006] In order to achieve the above object, the present invention provides a groove structure, comprising: a body, a groove and a drug coating; the groove is located on the body, a portion of the outer surface of the body forms a groove shoulder, and the groove shoulder is located on at least one side of the opening of the groove;

[0007] A portion of the drug coating is received in the groove, and another portion of the drug coating covers at least a portion of the groove shoulder.

[0008] Optionally, the groove is open along a first direction; the drug coating comprises a first portion and a second portion, the first portion is accommodated in the groove; the second portion covers at least a portion of the groove shoulder;

[0009] The total volume of the drug coating is V, the volume of the first part is V1, and the volume of the second part is V2, then 0.6≤V1 / V≤0.99 is satisfied.

[0010] Optional, 0.02≤V2 / V1≤0.2.

[0011] Optionally, the first direction is perpendicular to the axial direction of the body.

[0012] Optionally, the maximum radial distance between the bottom of the groove and the outer surface of the second part is D, the maximum radial thickness of the first part is D1, and the maximum radial thickness of the second part is D2, then 0.1≤D1 / D≤1, 0.01≤D2 / D≤0.4 is satisfied.

[0013] Optionally, the surface area of ​​the groove shoulder is S, and the surface area of ​​the second part is S1, then 0.05≤S1 / S≤1 is satisfied.

[0014] Optionally, the second portion has a protrusion at a position of the groove shoulder close to the groove, and the protrusion protrudes outward along the first direction, the first direction is perpendicular to the axial direction of the body and faces the outer surface of the body.

[0015] Optionally, the groove shoulder has a second groove, the second groove is open along the first direction, and the first direction is perpendicular to the axial direction of the body; at least a part of the second part is embedded in the second groove.

[0016] Optionally, the second groove extends along the axial direction of the body, or the second groove is in a point shape.

[0017] Optionally, the outer surface of the first part protrudes outward along the first direction, the first direction is perpendicular to the axial direction of the body and toward the outer surface of the body, the maximum radial thickness between the bottom of the groove and the outer surface of the second part is D, the maximum radial thickness of the first part is D1, and the maximum radial thickness of the second part is D2, then 1≤D1 / D≤1.3, 0.01≤D2 / D≤0.4 are satisfied.

[0018] Optionally, the body includes a protrusion disposed in the groove, and the first part wraps the protrusion.

[0019] Optionally, the groove shoulder and the groove constitute a medicine application surface, the projection area of ​​the medicine application surface along the first direction is N, and the surface area of ​​the groove shoulder is S, then 0.05≤S / N≤0.4 is satisfied.

[0020] In order to achieve the above object, the present invention also provides a medical stent, including a wave rod and a connecting portion, wherein the wave rods are connected end to end in sequence to form an annular component, the connecting portion connects adjacent annular components, and the wave rod includes the groove structure as described above.

[0021] Optionally, the groove structure is located on the outer surface of the wave rod, and the outer surface of the wave rod is the surface that contacts the blood vessel after implantation.

[0022] In summary, the present invention provides a groove structure and a medical stent, wherein the groove structure comprises: a body, a groove and a drug coating; the groove is located on the body, a portion of the outer surface of the body forms a groove shoulder, and the groove shoulder is located on at least one side of the groove opening; a portion of the drug coating is accommodated in the groove, and another portion of the drug coating covers at least a portion of the groove shoulder. Compared with the existing grooved stent, it has the following advantages:

[0023] (1) A portion of the drug coating is contained in the groove, and another portion covers at least a portion of the groove shoulder. The operator can control the release rate of the drug coating by loading the drug in the groove shoulder and adjusting the thickness of the drug coating inside the groove;

[0024] (2) Furthermore, a second groove is provided on the groove shoulder, and at least a portion of the drug coating is embedded in the second groove, thereby reducing the overflow of the drug coating during spraying, thereby reducing the risk of the drug coating falling off, and at the same time, improving the bonding strength between the drug coating and the groove shoulder;

[0025] (3) Furthermore, a protrusion is provided in the groove, and the drug coating is coated on the protrusion, which reduces the distance between the bottom of the drug coating and the surface of the vascular tissue, so that the drug coating can be released faster in the early stage of implantation, and the release rate of the drug coating in the middle and late stages can be further regulated, and the bonding strength between the drug coating and the groove bottom is also improved;

[0026] (4) Furthermore, the width of the groove shoulder is further narrowed on the outer surface of the body, which increases the contact area between the drug coating and the vascular tissue and improves the release rate of the drug coating. At the same time, it can also prevent the drug coating on the groove shoulder from being scratched and falling off, thereby reducing the risk of acute thrombosis. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 is a graph showing the relationship between drug release rate and time;

[0028] Figure 2A schematic diagram of a groove structure provided by an embodiment of the present invention;

[0029] Figure 3 A schematic diagram of a drug coating provided by an embodiment of the present invention;

[0030] Figure 4 A plan view of a wave rod with a groove structure provided by an embodiment of the present invention;

[0031] Figure 5 A schematic diagram of drug coating distribution provided by an embodiment of the present invention;

[0032] Figure 6 A cross-sectional view of a wave rod with a groove structure provided by an embodiment of the present invention;

[0033] Figure 7 A cross-sectional view of another wave rod with a groove structure provided by an embodiment of the present invention;

[0034] Figure 8 for Figure 7 Schematic diagram of drug loss during use of the grooved wave rod;

[0035] Fig. 9 A plan view of another wave rod with a groove structure provided by an embodiment of the present invention;

[0036] Fig.10 A plan view of another wave rod with a groove structure provided by an embodiment of the present invention;

[0037] Fig.11 A cross-sectional view of another groove structure provided by an embodiment of the present invention;

[0038] Fig.12 A cross-sectional view of another wave rod with a groove structure provided by an embodiment of the present invention;

[0039] Fig.13 A cross-sectional view of another wave rod with a groove structure provided by an embodiment of the present invention;

[0040] Fig.14 A cross-sectional view of another wave rod with a groove structure provided by an embodiment of the present invention;

[0041] Fig.15 A partial schematic diagram of a medical stent provided in an embodiment of the present invention.

[0042] The descriptions of the reference numerals are as follows:

[0043] 1-main body; 2-drug coating; 3-connecting part; 4-first direction; 5-wave rod; 11-groove; 12-groove shoulder; 21-first part; 22-second part; 111-protrusion; 121-second groove. DETAILED DESCRIPTION

[0044] In order to make the purpose, advantages and features of the present invention clearer, the present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments. It should be noted that the drawings are all in a very simplified form and are not drawn to scale, and are only used to conveniently and clearly assist in explaining the purpose of the embodiments of the present invention. In addition, the structure shown in the drawings is often a part of the actual structure. In particular, the emphasis of each drawing is different, and sometimes different scales are used.

[0045] As used in this specification, the singular forms "a", "an" and "the" include plural objects, the term "or" is generally used to include the meaning of "and / or", the term "several" is generally used to include the meaning of "at least one", and the term "at least two" is generally used to include the meaning of "two or more". In addition, the terms "first", "second" and "third" are used for descriptive purposes only and cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first", "second" and "third" may explicitly or implicitly include one or at least two of the features, "one end" and "the other end" and "the proximal end" and "the distal end" generally refer to two corresponding parts, which include not only the endpoints, and the terms "installed", "connected" and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral body; it can be directly connected or indirectly connected through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements. In addition, as used in this specification, an element disposed on another element generally only indicates that there is a connection, coupling, cooperation or transmission relationship between the two elements, and the connection, coupling, cooperation or transmission between the two elements may be direct or indirect through an intermediate element, and it cannot be understood as indicating or implying the spatial position relationship between the two elements, that is, one element may be in any orientation such as inside, outside, above, below or on one side of another element, unless the content clearly indicates otherwise. The terms "upper", "lower", "top" and "bottom" are generally relative position relationships arranged in the direction of gravity; the terms "vertical, vertical direction" generally refer to the direction of gravity, which is generally perpendicular to the ground, and "horizontal, horizontal plane direction" generally refers to the direction parallel to the ground; for ordinary technicians in this field, the specific meanings of the above terms in this specification can be understood according to specific circumstances.

[0046] The purpose of the present invention is to provide a groove structure and a medical stent to solve the problem that the existing stent cannot take into account both the controlled drug release rate and the drug firmness.

[0047] The inventors found that although the grooved drug loading method can effectively inhibit the proliferation of smooth muscle cells by effectively applying the drug coating to the time window of smooth muscle proliferation; however, it will also affect the drug release rate due to the different components in the drug groove, and the structure of the drug groove will also affect the drug release mechanism and the firmness of the drug coating in the drug groove. The existing grooved drug loading method will cause the risk of drug falling off while ensuring the size of the drug loading amount, and the drug release rate is not easy to control. Based on this, the inventors further optimized the structure of the drug groove. On the basis of drug loading in the drug groove, a part of the drug coating is loaded on the groove shoulder, and through experiments it is found that this structure can further control the drug release rate and reduce the loss of drug coating during stent implantation while meeting the drug loading amount. Specific experiments such as Figure 1 As shown in Table 1:

[0048] Table 1 Relationship between release rate and drug slot structure

[0049] Coating morphology at grooved area 7d release rate 28d release rate There is medicine in the shoulder groove 3%~40% 30%~80% No medicine for shoulder groove 2%~20% 30%~60%

[0050] Please refer to Figure 2 and Figure 3 The present invention provides a groove structure, comprising: a body 1, a groove 11 and a drug coating 2; the groove 11 is located on the body 1, a portion of the outer surface of the body 1 forms a groove shoulder 12, and the groove shoulder 12 is located on at least one side of the opening of the groove 11; a portion of the drug coating 2 is accommodated in the groove 11, and another portion of the drug coating 2 covers at least a portion of the groove shoulder 12. Optionally, in Figure 2 In the illustrated example, the cross section of the body 1 is a rounded rectangle. In other embodiments, the cross section of the body 1 may also be a circle, a rectangle, a trapezoid or other irregular shapes, and the present invention is not limited thereto.

[0051] With such configuration, a portion of the drug coating 2 is accommodated in the groove 11 of the main body 1, and the other portion covers at least a portion of the groove shoulder 12. The groove shoulder 12 and the groove 11 provide storage space for the drug coating 2. At the same time, the operator can control the release rate of the drug coating 2 by loading the drug through the groove shoulder 12 or changing the thickness of the drug coating 2 in the groove 11, further improving the practicality of the medical stent including the groove structure.

[0052] As an optional embodiment, please refer to Figure 3, the groove 11 is open along a first direction 4, and the first direction 4 is perpendicular to the axial direction of the body; the drug coating 2 includes a first part 21 and a second part 22, and the first part 21 is accommodated in the groove 11; the second part 22 covers at least a part of the groove shoulder 12; the total volume of the drug coating 2 is V, the volume of the first part 21 is V1, and the volume of the second part 22 is V2, then 0.6≤V1 / V≤0.99 is satisfied, or 0.02≤V2 / V1≤0.2 is satisfied. Preferably, 0.8≤V1 / V≤0.98, or 0.03≤V2 / V1≤0.1. It should be noted that in the body 1, the first direction 4 is perpendicular to the axial direction of the body 1 and faces the outer surface of the body 1; and in the stent, the first direction 4 is perpendicular to the axial direction of the stent wave rod and faces the outer surface of the stent. With such configuration, when V1 / V is less than the minimum value of the above ratio range, the first part 21 cannot reach a sufficient drug loading amount, thereby affecting the therapeutic effect on vascular tissue; when V1 / V is greater than the maximum value of the above ratio range, the amount of the first part 21 is too large, so that the drug coating 2 is easy to fall off from the groove 11 during the delivery process. When V2 / V1 is less than the minimum value of the above ratio range, the amount of the second part 22 is too small, thereby failing to meet the effect of controlling the release rate of the drug coating 2; when V2 / V1 is greater than the maximum value of the above ratio range, the amount of the second part 22 is too large, and it is easy to be scratched and fall off during the delivery process, thereby increasing the risk of acute thrombosis.

[0053] For further information, please continue to refer to Figure 3 , the maximum radial thickness between the bottom of the groove 11 and the outer surface of the second part 22 is D, the maximum radial thickness of the first part 21 is D1, and the maximum radial thickness of the second part 22 is D2, then 0.1≤D1 / D≤1, 0.01≤D2 / D≤0.4 are satisfied. Preferably, 0.5≤D1 / D≤0.95, 0.03≤D2 / D≤0.2. It should be noted that when D1 / D is less than the minimum value of the above-mentioned ratio range, the amount of the first part 21 is too small, thereby affecting the therapeutic effect on the vascular tissue; when D1 / D is greater than the maximum value of the above-mentioned ratio range, the amount of the first part 21 is too large, so that the drug coating 2 is easy to fall off from the groove 11 during the delivery process. When D2 / D is less than the minimum value of the above-mentioned ratio range, the amount of the second part 22 is accordingly too small, thereby failing to control the release efficiency of the drug coating 2; when D2 / D is greater than the maximum value of the above-mentioned ratio range, the amount of the second part 22 is accordingly too large, thereby causing the drug coating 2 to be easily scratched and fall off during transportation.

[0054] For further information, please refer to Figure 4 and Figure 5, the surface area of ​​the groove shoulder 12 is S, the surface area of ​​the second portion 22 is S1, then 0.05≤S1 / S≤1 is satisfied. Preferably, 0.4≤S1 / S≤0.95, more preferably, 0.7≤S1 / S≤0.95. It should be noted that Figure 4 and Figure 5 In the illustrated example, the outer surface of the second portion 22 is flat, and S1 / S defines the ratio of the surface area of ​​the second portion 22 to the surface area of ​​the groove shoulder 12. In such a configuration, when S1 / S is less than the minimum value of the above ratio range, the amount of the second portion 22 is too small, and the release efficiency of the drug coating 2 cannot be controlled; when S1 / S is greater than the maximum value of the above ratio range, the amount of the second portion 22 is too large, and it is easy to be scratched and fall off during transportation.

[0055] As an optional embodiment, please refer to Figure 6 The outer surface of the first portion 21 is recessed inwardly along the first direction 4, and in a certain cross section (in the axial direction of the groove structure) Figure 5 In the figure (where the cross section is along the first direction 4), the total cross-sectional area of ​​the drug coating 2 is M, the cross-sectional area of ​​the first part 21 is M1, and the cross-sectional area of ​​the second part 22 is M2, then 0.05≤M2 / M≤0.9, or 0.2≤M2 / M1≤0.9 is satisfied. Preferably, 0.2≤M2 / M≤0.5, or 0.35≤M2 / M1≤0.65. It should be noted that the outer surface of the first part 21 is recessed inwardly along the first direction 4, and the operator can effectively control the release of the drug coating 2 according to the maximum radial thickness of the first part 21 and the maximum radial thickness of the second part 22. At the same time, the drug coating 2 can also be prevented from being scratched and falling off. In addition, the shape of the outer surface of the first part 21 that is recessed inwardly along the first direction 4 can further prevent the drug coating 2 from being scratched and falling off, compared with the shape that protrudes outwardly or is parallel to the notch, and can increase the surface area of ​​drug release. By adjusting the degree of recessing, the drug release rate can be controlled. Figure 6 In the illustrated example, the bottom of the groove 11 is a smooth bottom, and the groove shoulder 12 is a flat groove shoulder 12. Of course, in other embodiments, the bottom of the groove 11 and the groove shoulder 12 may both be rough surfaces or have certain protrusions or depressions. Those skilled in the art may configure this according to actual conditions, and the present invention is not limited to this.

[0056] As a preferred embodiment, the outer surface of the first portion 21 is concave inwardly along the first direction 4, and the second portion 22 has a protrusion at a position of the groove shoulder 12 close to the groove 11, and the protrusion protrudes outwardly along the first direction 4. Figure 7In the illustrated example, the second portion 12 has a protrusion on the inner side of the groove shoulder 12 (i.e., the position where the groove shoulder 12 is close to the groove 11), and accordingly, the second portion 12 is relatively flat on the outer side of the groove shoulder 12 (i.e., the position where the groove shoulder 12 is away from the groove 11) or gradually decreases in the direction away from the groove. The thickness of the second portion 12 on the outer side of the groove shoulder 12 (i.e., the position where the groove shoulder 12 is away from the groove 11) is Figure 7 The thickness along the first direction 4 is smaller than the thickness on the inner side of the groove shoulder 12. With such configuration, after the stent is implanted, the protrusion can be preferentially attached to the blood vessel wall, accelerating the release rate of the drug coating within 28 days, so that the drug content per unit blood vessel wall is higher; at the same time, within 28 to 90 days, the drug will be released successively, and the entire release cycle is highly consistent with the proliferation cycle of smooth muscle cells, which can better prevent restenosis after stent implantation; in addition, when the stent is implanted, it passes through the microcatheter and more tortuous blood vessels to reach the lesion site, because the drug thickness at the edge of the wave rod is small, the second part 22 is only slightly rolled up at the place with greater friction (the state at this time is as shown in FIG. Figure 8 As shown in the figure), the drug loss rate is effectively reduced and the sufficient amount of medication is ensured.

[0057] Please refer to Figures 9 to 11 , the groove shoulder 12 has a second groove 121, and the second groove 121 is open along the first direction 4; at least a part of the second part 22 is embedded in the second groove 121. In this configuration, at least a part of the second part 22 is embedded in the second groove 121, which can prevent the drug coating 2 from overflowing during spraying, making the entire spraying process more stable; at the same time, the setting of the second groove 121 can also increase the bonding strength between the second part 22 and the groove shoulder 12, so that the drug coating 2 is not easily scratched and fallen off during transportation, thereby reducing the risk of causing acute thrombosis.

[0058] Furthermore, the second groove 121 extends along the axial direction of the body 1, or the second groove 121 is in a point shape. Fig. 9 In the illustrated example, the second groove 121 extends along the axial direction of the body 1; Fig.10 In the illustrated example, the second grooves 121 are distributed in dots on the outer surface of the groove shoulder 12; in other embodiments, the second grooves 121 may also be triangular, elliptical or an irregular shape formed by a combination of several shapes. Those skilled in the art may configure this according to actual conditions, and the present invention is not limited to this.

[0059] Please refer to Fig.12, the outer surface of the first part 21 protrudes outward along the first direction 4, the maximum radial thickness of the groove bottom of the groove 11 and the outer surface of the second part 22 is D, the maximum radial thickness of the first part 21 is D1, and the maximum radial thickness of the second part 22 is D2, then 1≤D1 / D≤1.3, 0.01≤D2 / D≤0.4 are satisfied. Preferably, 1≤D1 / D≤1.15, 0.03≤D2 / D≤0.2. It should be noted that according to the response of vascular tissue to different periods of medical stent implantation, after the medical stent is implanted, the damage to the inner wall of the blood vessel will lead to a large amount of migration and proliferation of smooth muscle, and the proliferation of smooth muscle cells reaches its peak on the 28th day. The outer surface of the first part 21 protrudes outward along the first direction 4, which can make the drug coating 2 quickly released in the first few days after the medical stent is implanted, and the release rate will reach more than 70% at 28 days, and the drug coating 2 can be continuously released from 28 days to 90 days, the key period of smooth muscle proliferation, so as to provide continuous and effective treatment to the target position. Those skilled in the art may configure the drug coating 2 according to different usage scenarios of the medical stent, and the present invention is not limited thereto.

[0060] Please refer to Fig.13 , the body 1 includes a raised portion 111 disposed in the groove 11, and the first portion 21 wraps the raised portion 111. With such a configuration, the raised portion 111 is disposed in the groove 11, which reduces the contact distance between the outer surface of the first portion 21 and the vascular tissue, and can further regulate the release rate of the drug coating 2; at the same time, the raised portion 111 can increase the bonding strength between the drug coating 2 and the bottom of the groove 11, so that the drug coating 2 is not easily scratched and falls off. Fig.12 In the illustrated example, the protrusion 111 is disposed at the bottom of the groove 11 . In other embodiments, the protrusion 111 may also be disposed at both sides of the groove 11 , and the present invention is not limited thereto.

[0061] Please refer to Fig.14 , the groove shoulder 12 and the groove 11 constitute a drug application surface, the projection area of ​​the drug application surface along the first direction 4 is N, and the surface area of ​​the groove shoulder 12 is S, then 0.05≤S / N≤0.4 is satisfied. Preferably, 0.1≤S / N≤0.35. With such a configuration, the surface area of ​​the groove shoulder 12 is further reduced, which can increase the contact area between the first part 21 and the vascular tissue, and facilitate the regulation of the release rate of the drug coating 2; at the same time, it also avoids the risk of the second part 22 being scratched and falling off, further reducing the probability of causing acute thrombosis. It should be noted that when S / N is less than the minimum value of the above-mentioned ratio range, the surface area of ​​the groove shoulder 12 is too small, so that the groove shoulder 12 will become too sharp, and there is a risk of scratching the vascular tissue; when S / N is greater than the maximum value of the above-mentioned ratio range, the surface area of ​​the groove shoulder 12 is too large, and the second part 22 is easy to be scratched and fall off, thereby increasing the risk of causing acute thrombosis.

[0062] As an optional embodiment, the shape of the groove 11 can be one or more combinations of cylindrical, rectangular and triangular prism shapes, the longitudinal section shape of the groove 11 can be one or more combinations of circular, long strip, polygonal, wavy, and annular shapes, and the cross-sectional shape of the groove 11 can be one or more combinations of arc, quadrilateral, semicircular, triangular, polygonal, wavy, serrated, and irregular shapes. It should be noted that the longitudinal section refers to a section parallel to the outer surface of the support rod, and the cross section refers to a section perpendicular to the axial direction of the support rod. Those skilled in the art can select a suitable cross-sectional shape according to actual conditions, and this embodiment is not limited to this.

[0063] Please refer to Fig.15 In order to achieve the above object, the present invention further provides a medical stent, comprising a wave rod 5 and a connecting portion 3, wherein the wave rod 5 is connected end to end through the connecting portion 3 to form an annular component, and the annular component is connected through a connecting rod 6, and the wave rod 5 includes the groove structure as described above. Optionally, the groove structure is located on the outer surface of the wave rod 5, and the outer surface of the wave rod 5 is the surface that contacts the blood vessel after implantation. It should be noted that in Fig.15 In the illustrated example, the grooved wave rods 5 are alternately connected in sequence to form an annular component, and the two annular components are connected by a connecting rod 6. Fig.15 Only part of the medical stent is shown in the figure. The complete medical stent is composed of multiple parts such as Fig.15 The annular component and the connecting portion 3 shown are repeatedly superimposed and connected to form a tubular object. In different embodiments, the annular component includes 1 to 10 groove structures. The wave rods 5 with groove structures are connected end to end to form an annular component, and the annular components are sequentially connected in the axial direction through the connecting rod 6 to form a stent. When the shape of the connecting rod 6 is a non-straight rod shape, such as a wavy, annular, or "Ω" shape, it is beneficial to the contraction and expansion process of the stent as a whole, which is a better solution.

[0064] As a preferred embodiment, the width of the groove structure is greater than the width of the connecting portion 3. With such configuration, the groove structure can accommodate enough drug coating 2, thereby ensuring the therapeutic effect on vascular tissue.

[0065] In summary, in a groove structure and a medical stent provided in an embodiment of the present invention, the groove structure includes: a main body, a groove and a drug coating; a portion of the outer surface of the main body forms a groove shoulder; a portion of the drug coating is accommodated in the groove, and another portion of the drug coating covers at least a portion of the groove shoulder.

[0066] With such configuration, a portion of the drug coating is accommodated in the groove, and the other portion covers at least a portion of the groove shoulder. The operator can control the release rate of the drug coating by loading the drug on the groove shoulder and adjusting the thickness of the drug coating inside the groove. Furthermore, a second groove is provided on the groove shoulder, and at least a portion of the drug coating is embedded in the second groove, which reduces the overflow of the drug coating during spraying, thereby reducing the risk of the drug coating falling off, and at the same time, improves the bonding strength between the drug coating and the groove shoulder. Furthermore, a raised portion is provided in the groove, and the drug coating is coated on the raised portion, which reduces the distance between the drug coating and the vascular tissue, improves the release rate of the drug coating, and also improves the bonding strength between the drug coating and the groove bottom. Furthermore, the proportion of the groove shoulder in the main body is further reduced, which increases the contact area between the drug coating and the vascular tissue, improves the release rate of the drug coating, and at the same time, it can also prevent the drug coating on the groove shoulder from being scratched and falling off, thereby reducing the risk of acute thrombosis.

[0067] The above description is only a description of the preferred embodiments of the present invention, and is not intended to limit the scope of the present invention. Any changes or modifications made by a person skilled in the art in the field of the present invention based on the above disclosure shall fall within the scope of protection of the claims.

Claims

1. A groove structure, It is characterized in that include: A body, a groove and a drug coating; the groove is located on the body, a portion of the outer surface of the body forms a groove shoulder, and the groove shoulder is located on at least one side of the opening of the groove; A portion of the drug coating is received in the groove, and another portion of the drug coating covers at least a portion of the groove shoulder.

2. The groove structure according to claim 1, It is characterized in that The groove is open along a first direction; the drug coating comprises a first portion and a second portion, the first portion is accommodated in the groove; the second portion covers at least a portion of the groove shoulder; The total volume of the drug coating is V, the volume of the first part is V1, and the volume of the second part is V2, then 0.6≤V1 / V≤0.99 is satisfied.

3. The groove structure according to claim 2, It is characterized in that 0.02≤V2 / V1≤0.

2.

4. The groove structure according to claim 2, It is characterized in that The first direction is perpendicular to the axial direction of the body.

5. The groove structure according to claim 2, It is characterized in that The maximum radial distance between the groove bottom and the outer surface of the second part is D, the maximum radial thickness of the first part is D1, and the maximum radial thickness of the second part is D2, then 0.1≤D1 / D≤1, 0.01≤D2 / D≤0.4 is satisfied.

6. The groove structure according to claim 2, It is characterized in that The surface area of ​​the groove shoulder is S, and the surface area of ​​the second portion is S1, then 0.05≤S1 / S≤1 is satisfied.

7. The groove structure according to claim 2, It is characterized in that The second portion has a protrusion at a position of the groove shoulder close to the groove. The protrusion protrudes outward along the first direction. The first direction is perpendicular to the axial direction of the body and faces the outer surface of the body.

8. The groove structure according to claim 2, It is characterized in that The groove shoulder has a second groove, the second groove is open along the first direction, and the first direction is perpendicular to the axial direction of the body; at least a part of the second part is embedded in the second groove.

9. The groove structure according to claim 8, It is characterized in that The second groove extends along the axial direction of the body, or the second groove is in a point shape.

10. The groove structure according to claim 2, It is characterized in that The outer surface of the first part protrudes outward along the first direction, the first direction is perpendicular to the axial direction of the body and faces the outer surface of the body, the maximum radial thickness between the bottom of the groove and the outer surface of the second part is D, the maximum radial thickness of the first part is D1, and the maximum radial thickness of the second part is D2, then 1≤D1 / D≤1.3, 0.01≤D2 / D≤0.4 are satisfied.

11. The groove structure according to claim 2, It is characterized in that The body includes a protrusion disposed in the groove, and the first portion wraps the protrusion.

12. The groove structure according to claim 11, It is characterized in that The groove shoulder and the groove constitute a medicine application surface, the projection area of ​​the medicine application surface along the first direction is N, and the surface area of ​​the groove shoulder is S, then 0.05≤S / N≤0.4 is satisfied.

13. A medical stent, It is characterized in that It comprises a wave rod and a connecting part, wherein the wave rods are connected end to end in sequence to form an annular component, the connecting part connects adjacent annular components, and the wave rod comprises the groove structure according to claims 1 to 10.

14. The medical stent according to claim 13, It is characterized in that The groove structure is located on the outer surface of the wave rod, and the outer surface of the wave rod is the surface that contacts the blood vessel after implantation.